跳至主要内容
临床试验/EUCTR2006-000110-21-DE
EUCTR2006-000110-21-DE进行中(未招募)不适用

An open, randomised parallel study investigating efficacy and safety of the human hepatitis B immunoglobulin BT088 after subcutaneous or intramuscular application for perinatal prophylaxis in infants born to HbsAg positive women

Biotest AG0 个研究点目标入组 31 人开始时间: 2006年7月31日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Biotest AG
入组人数
31

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Male or female neonate of gestational week = 37+0
  • Body weight = 2500 g
  • Apgar score, 5 minutes value > 7
  • Confirmation of HBsAg positive mother
  • Available written informed consent of parents or legal guardian
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Infant is too small for gestational age (i.e., < 2500 g)
  • Outpatient birth
  • Known or suspected intrauterine infection
  • (e.g. rubella, parvovirus B19, cytomegalovirus)
  • Complicated neonatal infection
  • Congenital malformation requiring major surgery
  • Known or suspected chromosomal aberration
  • Known or suspected intolerance to immunoglobulins
  • or comparable substances (e.g., vaccination reaction)
  • Known or suspected intolerance to proteins of human origin
  • Known deficiency of immunoglobulin A in the family
  • (parents and siblings of the neonate)
  • Suspected severe thrombocytopenia or any coagulation disorder
  • leading to contraindications for intramuscular injections
  • Any further condition which according to the investigator results
  • in an undue risk for the infant during participation in this study
  • Inability of the parents or the legal guardian to understand the
  • study-specific information and measures
  • Inability or lacking motivation of the parents or the legal guardian
  • to have the child participate in the study
  • Parents or legal guardian are employees of any involved study
  • investigator or any involved institution including study sponsor
  • Parallel participation of the infant in another clinical trial or
  • treatment with another investigational product during this study
  • Infants with an indwelling cannula for intravenous access

研究者

发起方
Biotest AG

相似试验

进行中(未招募)
不适用
An open, prospective, randomised parallel study investigating efficacy and safety of the human hepatitis B immunoglobulin BT088 after subcutaneous or intramuscular application in liver transplanted patientslong-term prophylaxis against hepatitis B re-infection = 3 months after liver transplantationMedDRA version: 8.0Level: LLTClassification code 10019731
EUCTR2005-003737-40-DEBiotest AG40
进行中(未招募)
不适用
An open, prospective, randomised parallel study investigating efficacy and safety of the human hepatitis B immunoglobulin BT088 after subcutaneous or intramuscular application in liver transplanted patients - NDlong-term prophylaxis against hepatitis B re-infection 3 months after liver transplantationMedDRA version: 9.1Level: LLTClassification code 10019731Term: Hepatitis B
EUCTR2005-003737-40-ITBIOTEST AG40
已完成
不适用
ifestyle Intervention in Independent Living Aged CareInfluence of diet change on cognition, mood and wellnessInfluence of diet change on blood biomarkers and cardiovascular healthInfluence of exercise change on cognition, mood and wellnessInfluence of exercise change on blood biomarkers and cardiovascular healthDiet and Nutrition - Other diet and nutrition disordersCardiovascular - Other cardiovascular diseasesMental Health - Studies of normal psychology, cognitive function and behaviour
ACTRN12614001133628Swinburne University of Technology208
进行中(未招募)
不适用
Gene Expression During an Energy Restricted Weight loss DietObesity in womenDiet and Nutrition - Obesity
ACTRN12609000385246CSIRO Human Nutrition16
已完成
不适用
Study in adult smokers to evaluate changes in biomarkers of tobacco exposure after switching to exclusive use of the JUUL2 systemTobacco exposure
ISRCTN27662176Juul (United States)96